NEW YORK (GenomeWeb News) – Exact Sciences today reported that its net loss for the quarter increased 14 percent on increased R&D spending and the recognition of revenues from its alliance with Genzyme announced earlier this year.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.